Company · CIK 0001875091 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
NeuroSense Therapeutics Ltd. · NRSN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 16, 2026 PForm 4 → | Jun 17, 4:30 pm EDT | Alon Ben-NoonChief Executive Officer | 250,000 | $0.80 | $200,000 | 4,534,233 | +5.84% | |
| Jun 16, 2026 PForm 4 → | Jun 17, 4:30 pm EDT | Or EisenbergChief Financial Officer | 250,000 | $0.80 | $200,000 | 1,504,050 | +19.9% |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.